NYSE:COV (COV) (COV) Stock Price, News & Analysis → Collect 10%+ Dividends from AI's Explosive Growth? (From The Oxford Club) (Ad) Free COV Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3.88 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (COV) alerts: Email Address Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. About (COV) Stock (NYSE:COV)Covidien Public Limited Company is a healthcare products company. The Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company’s brands include Kendall, Nellcor, Puritan Bennett and Valleylab, among others. It has a presence in more than 70 countries, with products sold in over 150 countries. The Company’s segments include Medical Devices and United States Medical Supplies. Medical Devices includes marketing of advanced and general surgical solutions, peripheral vascular and neurovascular therapies, patient monitoring products, and airway and ventilation products. United States Medical Supplies includes products, such as nursing care, medical surgical, SharpSafety and original equipment manufacturer (OEM) products. The Company’s products include Surgical Solutions, Vascular Therapies, Respiratory and Patient Care.Read More Ad The Oxford ClubCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having to buy a single stock?Click here now to claim your FREE copy of Marc's AI playbook. COV Stock News HeadlinesMay 29, 2024 | msn.comDoctors Warn About 2 New COVID Variants—What to Know About ‘FLiRT’ StrainsMay 28, 2024 | msn.comStudy shows enforced masking on long flights prevents SARS-CoV-2 transmissionMay 27, 2024 | msn.comRising COVID Cases: Essential Information on New FLiRT VariantsMay 26, 2024 | msn.comMaternal Covid infection may raise social and breathing troubles in babiesMay 26, 2024 | markets.businessinsider.comCost Plus Med Tech Launches Revolutionary At-Home Flu A/B & COVID-19 Multiplex Rapid TestMay 24, 2024 | msn.comHow COVID-19 'breakthrough' infections alter your immune cellsMay 24, 2024 | foxnews.comWhat to know about the new 'FLiRT' COVID variantsMay 23, 2024 | msn.comCork health officials on lookout for new 'FLiRT' Covid variantMay 23, 2024 | theglobeandmail.comClosing Bell: CI Hlth Care Giant Cov Call ETF down on Wednesday (FHI)May 23, 2024 | theglobeandmail.comClosing Bell: BMO US High Div Cov Call Hgd ETF up on Wednesday (ZWS)May 23, 2024 | msn.comChildren exposed to SARS-CoV-2 in womb or as newborns may face increased social and respiratory problemsMay 22, 2024 | msn.com100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseasesMay 20, 2024 | msn.comLVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variantsMay 18, 2024 | msn.comRepeat COVID-19 vaccinations elicit antibodies that neutralize variants, other virusesMay 17, 2024 | msn.comCould a cup of tea keep Covid-19 at bay?May 17, 2024 | msn.comPandemic treaty talks in Geneva get one final big pushMay 17, 2024 | msn.comA new COVID-19 variant, FLiRT, could cause a summer surge. These are the symptoms.May 17, 2024 | msn.comPre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%May 16, 2024 | theglobeandmail.comClosing Bell: CI Energy Giants Cov Call ETF flat on Friday (NXF)May 15, 2024 | msn.comCOVID-19 linked to rise in autoimmune lung disease, study findsMay 15, 2024 | msn.comNew COVID-19 'FLiRT' variants are now the dominant variant. Could there be a summer surge?May 15, 2024 | msn.comNew study identifies mechanism of immune evasion of SARS-CoV-2 and variantsMay 14, 2024 | msn.comStudy shows virus that causes COVID-19 can penetrate blood-retinal-barrier and could damage visionMay 14, 2024 | msn.comFinding the chink in coronavirus's armor—experiment reveals how the main protease of SARS-CoV-2 protects itselfMay 14, 2024 | msn.comCurcuminoid compounds show promise against COVID-19 in neuronal cellsSee More Headlines Receive COV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (COV) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/05/2014Today6/14/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNYSE:COV CUSIPG2554F11 CIK1385187 WebN/A Phone+353-1-4381700FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesGary L. Ellis (Age 61)President, Chief Executive Officer Charles J. Dockendorff (Age 63)Chief Financial Officer, Executive Vice President Bryan C. Hanson (Age 50)Group President, Covidien John H. Masterson (Age 54)Senior Vice President, General Counsel Michael P. Dunford (Age 54)Senior Vice President - Human Resources James C. Clemmer (Age 53)Senior Vice President and President - Medical Supplies Business Amy A. McBride-Wendell (Age 53)Senior Vice President - Strategy and Business Development Jacqueline F. Strayer (Age 58)Senior Vice President-Corporate Communications Michael E. Tarnoff (Age 46)Senior Vice President,Chief Medical Officer Peter L. Wehrly (Age 57)Senior Vice President, Group President - Developed Markets More ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGStrykerNYSE:SYKBoston ScientificNYSE:BSXMedtronicNYSE:MDTView All Competitors COV Stock Analysis - Frequently Asked Questions How were (COV)'s earnings last quarter? (COV) (NYSE:COV) issued its quarterly earnings results on Wednesday, November, 5th. The healthcare company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.02 by $0.13. The healthcare company had revenue of $2.73 billion for the quarter, compared to analysts' expectations of $2.69 billion. The company's revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.91 EPS. What other stocks do shareholders of (COV) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (COV) investors own include Pfizer (PFE), Chevron (CVX), Intel (INTC), Johnson & Johnson (JNJ), Boeing (BA), CVS Health (CVS), EMC (EMC), Gilead Sciences (GILD) and JPMorgan Chase & Co. (JPM). This page (NYSE:COV) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersPresident KamalaThe sneaky (yet 100% legal) way for Obama to return to power The ONLY way Democrats can keep the White Hous...Stansberry Research | SponsoredDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRIL...Paradigm Press | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (COV) Please log in to your account or sign up in order to add this asset to your watchlist. Share (COV) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.